discontinued

NBP1-54469-0.05 MICA antibody

See related secondary antibodies

Search for all "MICA"

50 µg / €280.00

Quick Overview

Mouse anti Human MICA BAMO3

NBP1-54469-0.05

Product Description for MICA

Mouse anti Human MICA BAMO3.
Presentation: Purified
Product is tested for Enzyme Immunoassay, Immunoprecipitation, Flow Cytometry.

Properties for MICA

Product Category Primary Antibodies
Quantity 50 µg
Presentation Purified
Reactivity Hu
Applications E, F, IP
Clonality Monoclonal
Clone BAMO3
Host Mouse
Isotype IgG2a
Shipping to Not USA/Canada
PDF datasheet View Datasheet
Manufacturer Novus Biologicals Inc.

Datasheet Extract

Immunogen
Swiss Prot Num:
Q96QC4
Immunogen:
The immunogen for this antibody is MICA. The exact immunogenic sequence is proprietary.
GeneID:
100507436
Isotype control AM03096PU-N
Background MICA encodes the higly polymorphic MHC (HLA) class I chain-related gene A. The protein product is expressed on the cell surface, although unlike canonical class I molecules does not seem to associate with beta-2-microglobulin. It is thought that MICA functions as a stress-induced antigen that is broadly recognized by intestinal epithelial gamma delta T cells. [provided by RefSeq]
Concentration 1 mg/ml
Storage Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Format
Purification:
Protein A purified
Buffer System:
PBS containing 50% glycerol, pH 7.2.
State:
Purified
Gene ID 4276

Accessory Products

Proteins and/or Positive Controls

Proteins for MICA (1 products)

Catalog No. Species Pres. Purity   Source  

MHC class I polypeptide-related sequence A (MICA), transcript variant 1 (allele MICA*00801).

MHC class I polypeptide-related sequence A (MICA), transcript variant 1 (allele MICA*00801). Human > 80 %
Preparation: or Add: Recombint proteins was captured through anti-DDK affinity column followed by conventiol chromatography steps.
Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining.
HEK293 cells
20 µg / €680.00
  OriGene Technologies, Inc.
  • LinkedIn